Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0HN6Q
|
||||
| Former ID |
DIB009831
|
||||
| Drug Name |
RG-7348
|
||||
| Synonyms |
MB-11362; Nucleosides (HepDirect, HCV infection), Roche/Metabasis
|
||||
| Indication | HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] | Phase 1 | [1] | ||
| Company |
Roche Holding AG
|
||||
| Target and Pathway | |||||
| Target(s) | Hepatitis C virus NS5B polymerase | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031996) | ||||
| REF 2 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.